Poland – Software implementation services – Dostawa, wdrożenie, konfiguracja, integracja, migracja danych, uruchomienie produkcyjne oraz przekazanie do eksploatacji zintegrowanego systemu ERP/CRM wraz z modułami dodatkowymi oraz zaprojektowanie, wdrożenie i uruchomienie szyny danych ESB/API, przeznaczonych do obsługi kluczowych procesów biznesowych Zamawiającego oraz zapewnienie interoperacyjnej wymiany danych pomiędzy systemami.

Poland – Passenger information system – Dostawa i montaż oraz utrzymanie Systemu Zliczania Pasażerów dla Operatorów ZTM

Poland – Software package and information systems – Dostawa oprogramowania do budowy chmury prywatnej - postępowanie w celu zawarcia umowy ramowej

Poland – Programming services of application software – Zaprojektowanie, wykonanie, wdrożenie oraz świadczenie asysty technicznej i konserwacji aplikacji SOZP 2.0 służącej do obsługi zamówień publicznych w Gminie Miejskiej Kraków oraz udzielenie licencji.

Poland – Security software development services – Wdrożenie i utrzymanie Systemu Zarządzania Bezpieczeństwem Informacji (SZBI) oraz SOC wraz ze szkoleniami w Samodzielnym Publicznym Szpitalu Klinicznym im. Prof. W. Orłowskiego CMKP w Warszawie

Poland – Computer equipment and supplies – „Dostawa sprzętu komputerowego wraz z oprogramowaniem, kserokopiarki i urządzeń sieciowych”

Poland – Technical computer support services – Zakup usługi nadzoru autorskiego oraz serwisu oprogramowania InfoMedica na okres 24 miesięcy.

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Outcome: This action will establish a strategic European initiative to develop scalable, modular, and interoperable photonic quantum computing platforms. Proposals for this topic are expected to address and provide credible solutions to at least two major technical roadblocks currently limiting the advancement of photonic quantum computing such as: The lack of deterministic, high-efficiency photonic entanglement and loss-tolerant architectures suitable for fault-tolerant scaling The absence of a standardised, integrated control stack combining photonic hardware, firmware, and system software with reliable benchmarking across platforms Project results are expected to contribute to the following expected outcomes: By 2028, demonstration of a photonic NISQ processor with ≥100 photonic qubits, integrating deterministic single-photon sources, low-loss waveguides, on-chip detectors, and a firmware stack (scheduler, controller, compiler), validated via hardware-agnostic benchmarks and hybrid photonic-HPC applications demonstrating classical-quantum crossover By 2030, delivery of a full-stack, high-connectivity photonic quantum computer, with modular scalability, integrated…

This program is not open to the public. Eligibility is determined by federal statute. Applications can only be accepted from the designated state authority or agency.

Established by Congress in fiscal year (FY) 1997, the Habitat Conservation Plan (HCP) Land Acquisition Grant program was designed to reduce conflicts between the conservation of listed species and competing land uses on specific parcels of land associated with approved and permitted HCPs. Under this program, the U.S. Fish and Wildlife Service (FWS) provides matching grants to State agencies in support of land acquisition projects that will conserve species habitat in perpetuity through fee simple acquisition or the acquisition of permanent conservation easements. FWS considers the use of Federal acquisition dollars by States for habitat protection associated with HCPs to be an important and effective mechanism to promote species recovery, prevent extinction, and preclude the need to list species under the Endangered Species Act (ESA) in the future. All land acquired through these grants complements, but does not replace, the mitigation, minimization, and/or monitoring commitments of the HCP. Thus, this work is additive to the conservation commitments entered into when HCPs are permitted and serves as a meaningful way to leverage non-Federal investment in species recovery and connect conservation lands across the landscape.